Devices › Device types
FDA product code DRC · class 2 · Cardiovascular
Trocar: medical device reports filed with FDA
2,003 reports carry this product code, 1992–2026; 16 brands with a page.
- 2,003
- reports with this product code
- 0% of all MAUDE reports
- 95
- reports, 12 months to August 2026
- 65 in the 12 months before
- 47.7%
- classified as malfunction
- 62.3% across all reports
- 2.9%
- classified as death, as reported
- 0.9% across all reports
Product code DRC is FDA's classification for "Trocar" (cardiovascular panel), a class 2 device. 2,003 medical device reports carry this product code, 0% of the MAUDE database, from January 1992 to August 2026.
95 reports arrived in the 12 months to August 2026, up 46% from 65 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (47.7%), injury (46.9%) and death (2.9%). 16 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Transseptal Needle, BRK Series | 202 | 32 | 5.9% | 2% |
| Spacemaker Blunt Tip Trocar 10mm | 190 | 0 | 0% | 95.1% |
| Spacemaker Blunt Tip Trocar 12mm | 84 | 0 | 0% | 94.1% |
| 5 5mm Short Secondary Port | 54 | 0 | 0% | 92.1% |
| Spacemaker Structural Balloon Trocar | 46 | 0 | 0% | 95.6% |
| Heartlight | 5 | 0 | 1% | 6.8% |
| Autosuture | 4 | 0 | 1.2% | 63.1% |
| Endopath | 4 | 74 | 1.4% | 83.7% |
| Argyle | 3 | 60 | 1% | 82.4% |
| Auto Suture | 3 | 234 | 0.1% | 94.6% |
| Ethicon | 3 | 164 | 2.3% | 54.2% |
| Sm Plus Btt/Oval Balloon Dissector | 2 | 0 | 0% | 94.3% |
| Endopath Xcel | 1 | 38 | 0.5% | 95.2% |
| Kendall | 1 | 23 | 2.3% | 61.5% |
| NRG Transseptal Needle | 1 | 24 | 4.2% | 25.9% |
| Spacemaker Preperitoneal Dist Balloon | 1 | 0 | 0% | 95.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Ponce - Uss | 339 | 16.9% |
| St Jude Medical | 263 | 13.1% |
| St Jude Medical Costa Rica Ltda | 140 | 7% |
| United States Surgical | 82 | 4.1% |
| Medtronic Mexico | 74 | 3.7% |
| Medtronic Mexico S De R L De Cv | 21 | 1% |
| Ethicon | 16 | 0.8% |
| Merit Medical Systems | 16 | 0.8% |
| Applied Medical Resources | 13 | 0.6% |
| Applied Medical | 11 | 0.5% |
| Ethicon Endo-Surgery | 7 | 0.3% |
| Cook | 4 | 0.2% |
| Codman & Shurtleff | 3 | 0.1% |
| Conmed | 2 | 0.1% |
| Ethicon Endo Surgery | 2 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 214 | 10.7% |
| Detachment of device component | 193 | 9.6% |
| Replace | 185 | 9.2% |
| Balloon rupture | 105 | 5.2% |
| Component(s), broken | 96 | 4.8% |
| Balloon burst | 94 | 4.7% |
| Device, removal of (non-implant) | 88 | 4.4% |
| Component falling | 86 | 4.3% |
| Disengaged | 67 | 3.3% |
| Difficult to insertthe device was hard to insert | 60 | 3% |
| Insufficient device problem information | 58 | 2.9% |
| Material separation | 50 | 2.5% |
| Activation, positioning or separation problem | 32 | 1.6% |
| Fracturea broken bone | 29 | 1.4% |
| Device, or device fragments remain in patient | 28 | 1.4% |
| Air leak | 26 | 1.3% |
| Trocar failure | 25 | 1.2% |
| Inflation problem | 23 | 1.1% |
| Difficult to removethe device was hard to remove | 18 | 0.9% |
| Material fragmentation | 18 | 0.9% |
Questions about trocar reports
What is product code DRC?
FDA's classification code for "Trocar", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,003 reports through August 2026, 95 of them in the latest 12 months.
Which brands appear most often?
Transseptal Needle, BRK Series (202), Spacemaker Blunt Tip Trocar 10mm (190), Spacemaker Blunt Tip Trocar 12mm (84), 5 5mm Short Secondary Port (54) and Spacemaker Structural Balloon Trocar (46). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.